BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25305131)

  • 21. miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-κB Signaling Pathway in Esophageal Squamous Cell Carcinoma.
    Mei LL; Wang WJ; Qiu YT; Xie XF; Bai J; Shi ZZ
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28832500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-1908-5p contributes to the oncogenic function of the splicing factor SRSF3.
    Kim HR; Shin CH; Lee H; Choi KH; Nam DH; Ohn T; Kim HH
    Oncotarget; 2017 Jan; 8(5):8342-8355. PubMed ID: 28039456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas.
    el Sayadi H; Pissaloux D; Alberti L; Tabone-Eglinger S; Ranchere D; Decouvelaere AV; Tabone E; Ray-Coquard I; Caux C; Fayette J; Blay JY
    Target Oncol; 2013 Dec; 8(4):261-9. PubMed ID: 23354874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HBx-induced MiR-1269b in NF-κB dependent manner upregulates cell division cycle 40 homolog (CDC40) to promote proliferation and migration in hepatoma cells.
    Kong XX; Lv YR; Shao LP; Nong XY; Zhang GL; Zhang Y; Fan HX; Liu M; Li X; Tang H
    J Transl Med; 2016 Jun; 14(1):189. PubMed ID: 27349221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of leiomyosarcoma of the uterus in MMTV-CR-1 transgenic mice.
    Strizzi L; Bianco C; Hirota M; Watanabe K; Mancino M; Hamada S; Raafat A; Lawson S; Ebert AD; D'Antonio A; Losito S; Normanno N; Salomon DS
    J Pathol; 2007 Jan; 211(1):36-44. PubMed ID: 17072826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncomirs Expression Profiling in Uterine Leiomyosarcoma Cells.
    de Almeida BC; Garcia N; Maffazioli G; dos Anjos LG; Baracat EC; Carvalho KC
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation, proliferation and apoptosis levels in human leiomyoma and leiomyosarcoma.
    Valenti MT; Azzarello G; Vinante O; Manconi R; Balducci E; Guidolin D; Chiavegato A; Sartore S
    J Cancer Res Clin Oncol; 1998; 124(2):93-105. PubMed ID: 9654192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functionality of the Tumor Suppressor
    Stope MB; Cernat V; Kaul A; Diesing K; Koensgen D; Burchardt M; Mustea A
    Anticancer Res; 2018 Mar; 38(3):1547-1550. PubMed ID: 29491084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copper ions are novel therapeutic agents for uterine leiomyosarcoma.
    Kakuda M; Matsuzaki S; Ueda Y; Shiomi M; Matsuzaki S; Kimura T; Fujita M; Egawa-Takata T; Kobayashi E; Serada S; Yoshino K; Naka T; Kimura T
    Am J Obstet Gynecol; 2020 Jan; 222(1):64.e1-64.e16. PubMed ID: 31351063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatty acid synthase reprograms the epigenome in uterine leiomyosarcomas.
    Guan M; Wu X; Chu P; Chow WA
    PLoS One; 2017; 12(6):e0179692. PubMed ID: 28654693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro.
    Li F; Liang A; Lv Y; Liu G; Jiang A; Liu P
    Med Sci Monit; 2017 Oct; 23():5139-5149. PubMed ID: 29080395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism.
    Shi R; Xiao H; Yang T; Chang L; Tian Y; Wu B; Xu H
    Front Med; 2014 Dec; 8(4):456-63. PubMed ID: 25363395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
    He C; Wang L; Zhang J; Xu H
    Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pioglitazone induces cell growth arrest and activates mitochondrial apoptosis in human uterine leiomyosarcoma cells by a peroxisome proliferator-activated receptor γ-independent mechanism.
    Lützen U; Zhao Y; Lucht K; Zuhayra M; Marx M; Cascorbi I; Culman J
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):37-48. PubMed ID: 27664035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the mitogen-inducible gene-2 (mig-2) is elevated in human uterine leiomyomas but not in leiomyosarcomas.
    Kato K; Shiozawa T; Mitsushita J; Toda A; Horiuchi A; Nikaido T; Fujii S; Konishi I
    Hum Pathol; 2004 Jan; 35(1):55-60. PubMed ID: 14745725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2) are potential targets in uterine leiomyosarcoma.
    Nakamura K; Abarzua F; Hongo A; Kodama J; Nasu Y; Kumon H; Hiramatsu Y
    Int J Oncol; 2010 Sep; 37(3):605-14. PubMed ID: 20664929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uterine Leiomyosarcoma Tumorigenesis in Lmp2-deficient Mice: Involvement of Impaired Anti-oncogenic Factor IRF1.
    Hayashi T; Horiuchi A; Sano K; Yaegashi N; Konishi I
    Anticancer Res; 2015 Sep; 35(9):4665-79. PubMed ID: 26254356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-200c enhances sensitivity of drug-resistant non-small cell lung cancer to gefitinib by suppression of PI3K/Akt signaling pathway and inhibites cell migration via targeting ZEB1.
    Zhou G; Zhang F; Guo Y; Huang J; Xie Y; Yue S; Chen M; Jiang H; Li M
    Biomed Pharmacother; 2017 Jan; 85():113-119. PubMed ID: 27930974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcription factor and microRNA interactions in lung cells: an inhibitory link between NK2 homeobox 1, miR-200c and the developmental and oncogenic factors Nfib and Myb.
    Tagne JB; Mohtar OR; Campbell JD; Lakshminarayanan M; Huang J; Hinds AC; Lu J; Ramirez MI
    Respir Res; 2015 Feb; 16(1):22. PubMed ID: 25763778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential.
    O'Neill CJ; McBride HA; Connolly LE; McCluggage WG
    Histopathology; 2007 Jun; 50(7):851-8. PubMed ID: 17543074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.